BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 12748124)

  • 1. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
    Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
    Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
    Murphy SP; Tomasi TB
    Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control.
    Morris AC; Spangler WE; Boss JM
    J Immunol; 2000 Apr; 164(8):4143-9. PubMed ID: 10754309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression.
    Morris AC; Riley JL; Fleming WH; Boss JM
    Am J Reprod Immunol; 1998 Dec; 40(6):385-94. PubMed ID: 9894561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
    Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
    Dong Y; Rohn WM; Benveniste EN
    J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E; Greer SF; Zhu XS; Ting JP
    Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
    Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
    Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein.
    O'Keefe GM; Nguyen VT; Ping Tang LL; Benveniste EN
    J Immunol; 2001 Feb; 166(4):2260-9. PubMed ID: 11160280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA.
    van den Elsen PJ; van der Stoep N; Viëtor HE; Wilson L; van Zutphen M; Gobin SJ
    Hum Immunol; 2000 Sep; 61(9):850-62. PubMed ID: 11053628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
    Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
    J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of major histocompatibility complex class II gene expression in trophoblast cells.
    Murphy SP; Choi JC; Holtz R
    Reprod Biol Endocrinol; 2004 Jul; 2():52. PubMed ID: 15236650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines.
    van der Stoep N; Biesta P; Quinten E; van den Elsen PJ
    Int J Cancer; 2002 Feb; 97(4):501-7. PubMed ID: 11802213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
    Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL
    Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
    Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
    Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines.
    Tschickardt ME; Lu Y; Jacim M; Ussery GD; Steimle V; Mach B; Blanck G
    Int J Cancer; 1995 Aug; 62(4):461-5. PubMed ID: 7635572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha.
    Giroux M; Schmidt M; Descoteaux A
    J Immunol; 2003 Oct; 171(8):4187-94. PubMed ID: 14530341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of HLA class I gene transcription in choriocarcinoma cells is controlled by the proximal promoter element and can be reversed by CIITA.
    Lefebvre S; Moreau P; Dausset J; Carosella ED; Paul P
    Placenta; 1999 May; 20(4):293-301. PubMed ID: 10329350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.